Italy’s Wearable Robotics Secures €5 Million Series A to Propel Neuromotor Rehabilitation Technologies

In a significant milestone for the wearable robotics sector, Pisa-based startup Wearable Robotics has successfully closed a €5 million Series A funding round. This strategic infusion of capital aims to fuel the company's global expansion and enhance its groundbreaking technologies in neuromotor rehabilitation and exoskeleton development.

A Step Forward in Innovation

Founded in 2014 as a spin-off from the prestigious Scuola Superiore Sant’Anna, Wearable Robotics has swiftly become a leader in wearable robotics. The company focuses on creating advanced robotic devices for rehabilitation, movement assistance, and human capacity augmentation. By integrating augmented and virtual reality (AR/VR) with wearable robotics, the company seeks to revolutionize rehabilitation pathways, particularly focusing on Activities of Daily Living.

The recent funding round was spearheaded by CDP Venture Capital through the Accelerators Fund, with additional investments from MITO Technology, LIFTT, and SIMEST. The participation of RoboIT and Toscana Next further underscores the regional commitment to fostering innovation.

Expanding Horizons

The capital raised will be instrumental in expanding Wearable Robotics’ product portfolio and accelerating its commercial development. According to CEO Lucia Lencioni, the funds will support sustainable growth, product innovation, regulatory compliance, and the strengthening of commercial channels. “Our goal is to bring increasingly advanced and modular wearable robotics solutions, capable of generating a concrete impact along the entire rehabilitation continuum,” Lencioni stated.

Wearable Robotics operates two main divisions: NEXUM Medical, focusing on neuro-motor rehabilitation, and NEXUM Industry, which develops exoskeletons for industrial applications. The company’s flagship product, the ALEX RS device, is already a benchmark in rehabilitation robotics, with over 50 units installed globally.

Implications for the Startup Ecosystem

This funding round is a testament to the growing interest and investment in health tech and robotics. For startups and investors, Wearable Robotics exemplifies the potential of combining cutting-edge technology with strategic partnerships to drive growth and innovation. The company’s success highlights the importance of robust research foundations, as seen in its origins at Scuola Superiore Sant’Anna, and the value of a strong patent portfolio, with eight proprietary patents underpinning its offerings.

For founders and operators, Wearable Robotics’ journey emphasizes the significance of regulatory strength and market readiness. By prioritizing compliance and accelerating time-to-market, the startup is poised to capture significant market share, particularly in North America.

Looking Ahead

With a presence in 20 countries, Wearable Robotics is well-positioned for international growth. The funding will enhance its distribution network and facilitate entry into key markets, fostering new partnerships and expanding its global footprint. As the demand for innovative rehabilitation solutions grows, the company’s commitment to advancing wearable robotics technology promises to deliver substantial impacts on health outcomes worldwide.

In conclusion, Wearable Robotics’ successful Series A round not only marks a pivotal moment for the company but also signifies broader trends in the startup ecosystem. By leveraging strategic investments and focusing on innovation, the company sets a benchmark for aspiring health tech startups aiming to make a global impact.

Source: EU-Startups